What did a human red-ginseng study measure with midazolam?

Illustration of a microscope and slides on a bright laboratory bench

Written by

in

A metabolic probe can show how a specific supplement formulation affected a measured pathway under study conditions. The choice of endpoint affects how that evidence can be used.

Read the metabolic ratio

Kim and colleagues evaluated 14 healthy men before and after two weeks of a concentrated red-ginseng preparation. Their probe cocktail included midazolam and they measured its relationship to 1-hydroxymidazolam as a marker of CYP3A activity. The reported before-and-after comparison for this endpoint was 0.824, with a 90% confidence interval of 0.658 to 1.032. The authors did not identify a clinically significant interaction in their tested setting.

Identify the product before extrapolating

This was a small, open-label study of a defined preparation and a healthy cohort. A different ginseng extract, dose, exposure period or patient population may require its own data. For expert review, compare the label and dose with the tested product and distinguish a probe metabolite ratio from a measured clinical outcome such as sedation.

Read the original paper.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *